Arix Bioscience

Arix Bioscience, a UK-based research and development services company, reported total Scope 1, 2, and 3 emissions of approximately 13,300 kg CO2e in 2022. This comprised 3,680 kg CO2e from Scope 1, 8,890 kg CO2e from Scope 2 (market-based), and 5,210 kg CO2e from Scope 3 emissions.

The company aims to achieve net-zero operations by 2050 or sooner, targeting a reduction of over 90% of its emissions from a 2023 baseline. Additionally, Arix Bioscience has an intensity target to reduce carbon emissions by 40% in 2025 against a 2019 baseline, normalised to occupied areas.

In 2021, Arix Bioscience's total Scope 1, 2, and 3 emissions were approximately 15,360 kg CO2e, with Scope 1 at 4,860 kg CO2e, Scope 2 (market-based) at 7,800 kg CO2e, and Scope 3 at 2,900 kg CO2e. In 2020, the company's Scope 1 and 2 emissions totalled approximately 10,430 kg CO2e, with Scope 1 at 5,020 kg CO2e and Scope 2 (market-based) at 5,110 kg CO2e; Scope 3 data for 2020 was not disclosed.

For 2019, Arix Bioscience reported total Scope 1 and 2 emissions of approximately 17,100 kg CO2e, consisting of 11,500 kg CO2e from Scope 1 and 5,600 kg CO2e from Scope 2 (market-based). Scope 3 data for 2019 was not disclosed.